TY - JOUR
T1 - Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions
T2 - A randomized controlled trial in the general hospital setting (CC-DIM)
AU - Goorden, M.
AU - van der Feltz-Cornelis, C.M.
AU - van Steenbergen-weijenburg, K.M.
AU - Horn, E.K.
AU - Beekman, A.
AU - Hakkaart-van Roijen, L.
PY - 2017/7
Y1 - 2017/7
N2 - The study was undertaken to establish if collaborative care (CC) is a
cost-effective treatment model when provided in the general hospital
outpatient setting, rather than the primary care setting, for patients
with chronic physical conditions, such as diabetes mellitus (DM),
chronic heart failure (CHF), and chronic obstructive pulmonary disease
(COPD), with comorbid major depressive disorder (MDD). The researchers
performed a randomized controlled trial (RCT) evaluating CC provided by a
consultant psychiatric nurse (CPN) as care manager; a
consultation–liaison (CL) psychiatrist for diagnosis, supervision, and
the prescription of antidepressant medication; and a medical specialist
who provided treatment for the chronic physical condition. They found CC
to be cost-effective with an incremental cost-effectiveness ratio
(ICER) of €24,690 per quality-adjusted life year (QALY). Due to the high
disease burden in this patient group, this may indicate that the CC
model and setting may be preferable. However, the study was small, so
replication in a larger study is warranted.
AB - The study was undertaken to establish if collaborative care (CC) is a
cost-effective treatment model when provided in the general hospital
outpatient setting, rather than the primary care setting, for patients
with chronic physical conditions, such as diabetes mellitus (DM),
chronic heart failure (CHF), and chronic obstructive pulmonary disease
(COPD), with comorbid major depressive disorder (MDD). The researchers
performed a randomized controlled trial (RCT) evaluating CC provided by a
consultant psychiatric nurse (CPN) as care manager; a
consultation–liaison (CL) psychiatrist for diagnosis, supervision, and
the prescription of antidepressant medication; and a medical specialist
who provided treatment for the chronic physical condition. They found CC
to be cost-effective with an incremental cost-effectiveness ratio
(ICER) of €24,690 per quality-adjusted life year (QALY). Due to the high
disease burden in this patient group, this may indicate that the CC
model and setting may be preferable. However, the study was small, so
replication in a larger study is warranted.
U2 - 10.2147/NDT.S134008
DO - 10.2147/NDT.S134008
M3 - Article
VL - 13
SP - 1881
EP - 1893
JO - Neuropsychiatric Disease and Treatment
JF - Neuropsychiatric Disease and Treatment
SN - 1176-6328
ER -